Background/Aims Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in Europe. A further increase in the number of affected persons is expected and current ...

Aim To investigate the development of dissociated vertical deviation (DVD) in infantile esotropia and its relationship with the infant's age and the surgical intervention technique. Material and ...

Objective There has long been a great interest in neuroprotection therapy for ischaemic stroke and various types of optic neuropathies. In view of that, I reviewed the literature on the role of ...

Background/aims To investigate the influence of a period of sustained near work upon axial length in groups of emmetropes (EMM) and myopes. Methods Forty young adult subjects (20 myopes and 20 ...

Background/aims: The direct brow lift operation can be used to treat brow ptosis arising from either involutional changes or facial nerve palsy. The authors reviewed their experience with this ...

The treatment of diabetic macular oedema (DMO) likely involves a series of treatment episodes separated by gaps during which ...

AIM To define the clinical and microbiological profile of bacterial keratitis at the Jules Gonin Eye Hospital and to test the in vitro bacterial resistance. METHODS Patients presenting with bacterial ...

Background Acute dacryocystitis (AD) is primarily related to nasolacrimal duct obstruction and is associated with a high morbidity, particularly in the elderly. This study aims to determine ...

Background Diabetic retinopathy (DR) is a leading cause of blindness, with an increasing reliance on large language models ...

This study aims to assess the accuracy of CT imaging in estimating intraocular foreign body (IOFB) size by comparing pre-operative radiological measurements with post-surgical dimensions. A ...

Aim To assess if performing two visual field (VF) tests per eye on the same visit (frontloading) can increase perimetric data and decrease longitudinal variability compared with one test per eye.

Anti-vascular endothelial growth factor (VEGF) therapy has revolutionised the treatment of retinal disease, and appears to be very safe. Nevertheless, there are several lines of evidence that imply ...